Bonolive

Bonolive® is a patented olive leaf extract designed to support post-menopausal women and address concerns such as loss of bone mass, joint discomfort, and blood lipids disbalance.Bonolive® is standardized for highly bioavailable oleuropein (>40%), a powerful phytonutrient unique to the olive tree.At the cellular level, Bonolive® promotes bone formation by inhibiting adipocyte differentiation and enhancing differentiation into osteoblasts, the bone-building cells.Additionally, Bonolive® reduces levels of inflammation and cartilage degradation biomarkers, such as PGE-2 and collagen-II, that are involved in the process.Three clinical studies support bonolive® efficacy. A daily dose of 250 mg of Bonolive® results in the following health benefits:Increases bone metabolism biomarker osteocalcin by 32%Protects against loss of bone mass densityReduces joint painImproves joints mobilityImproves blood lipid profileBonolive® is water-soluble and has shown excellent bioavailability in humans. It can be formulated in various dietary supplement forms, including capsules, sachets, tablets, chewable, gummies, shots and shelf-stable drinks. Key applications:Post-menopausal women's healthOsteopenia, osteoporosis, and bone health supportOsteoarthritis and joint health